Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q4IE
|
|||
| Former ID |
DIB002365
|
|||
| Drug Name |
ARX-618
|
|||
| Synonyms |
PEG-FGF21A; FGF-21 like proteins (type 2 diabetes,metabolic disorders), Ambrx/Merck & Co; PEGylated-FGF-21 (type 2 diabetes/metabolic disorder), Merck/Ambrx
Click to Show/Hide
|
|||
| Indication | Metabolic disorder [ICD-11: 5C50-5D2Z; ICD-10: E70-E90; ICD-9: 270-279] | Investigative | [1] | |
| Company |
Ambrx Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.